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Sib Pair and Multiplex Families: Evidence for Genetic Epistasis
with Chromosome 16q12
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The presence of systemic lupus erythematosus (SLE) susceptibility genes on chromosome 20 is suggested by the
observation of genetic linkage in several independent SLE family collections. To further localize the genetic effects,
we typed 59 microsatellites in the two best regions, as defined by genome screens. Genotypes were analyzed for
statistical linkage and/or association with SLE, by use of a combination of nonparametric linkage methods, family-
based tests of association (transmission/disequilibrium and pedigree disequilibrium tests), and haplotype-sharing
statistics (haplotype runs test), in a set of 230 SLE pedigrees. Maximal evidence for linkage to SLE was to 20p12
( ) and 20q13.1 ( ) in the white pedigrees. Subsetting families on the basis of evidence forLODp 2.84 LODp 1.64
linkage to 16q12 significantly improved the LOD scores at both chromosome 20 locations (20p12 LODp 5.06
and 20q13 ), consistent with epistasis. We then typed 162 single-nucleotide polymorphism markersLODp 3.65
across a 1.3-Mb candidate region on 20q13.1 and identified several SNPs that demonstrated significant evidence
for association. These data provide additional support for linkage and association to 20p12 and 20q13.1 in SLE
and further refine the intervals of interest. These data further suggest the possibility of epistatic relationships among
loci within the 20q12, 20q13, and 16q12 regions in SLE families.
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Systemic lupus erythematosus (SLE [MIM 152700]) is
a heterogeneous, systemic autoimmune disease charac-
terized by the production of autoantibodies to a mul-
titude of self-antigens. SLE predominantly affects fe-
males, and prevalence rates and disease severity are
increased in several nonwhite groups.1–5 Clinical mani-
festations vary between individual patients, and there is
evidence for complex contributions of genetic and en-
vironmental factors to SLE from population and family-
based studies.6–11 Linkage studies in human SLE pedi-
grees have identified multiple regions that meet ge-
nomewide criteria for significant or suggestive linkage,12
which is consistent with the hypothesis that SLE is a
complex polygenic disease.13–26
Our group was one of the first to provide evidence
for linkage on chromosome 20 (D20S186, LODp
) in an initial study of 105 SLE sib pair pedigrees.152.62
The subsequent addition of 82 independent pedigrees
further refined the linkage signal with the emergence of
two peaks, one at 20p12 (D20S186, ) andLODp 1.77
one at 20q13.1 (D20S119, ).18 EvidenceLODp 1.64
supporting linkage to either 20p12 or 20q13 has been
identified in three additional, ethnically diverse family
collections.14,16,22 This concordance of evidence supports
the hypothesis that SLE susceptibility genes lie in these
regions.
In this report, we present the results of a dense fine-
mapping effort on chromosome 20 that used 59 micro-
satellite markers distributed across 20p12 and 20q13
and 162 SNP markers localized to a 1.3-Mb region of
maximal linkage on 20q13.1. These analyses were per-
formed in an expanded collection of 230 SLE multiplex
pedigrees, including 44 families not previously reported.
The expanded fine-map data set refines the linkage in-
tervals previously identified in our genome screens and
provides evidence for transmission distortion with sev-
eral SNP marker alleles. In addition, we apply an ordered
subset analysis (OSA), conditioned on linkage to chro-
mosome 16, that establishes evidence consistent with
genetic epistasis between loci on chromosome 16 and
20 and identifies a subset of families with enhanced link-
age and association to 20p12 and 20q13.1.
Material and Methods
SLE Families
Methods used for the recruitment of families have been de-
scribed elsewhere.27 The University of Minnesota Institutional
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Review Board for research on human subjects approved this
study, and informed consent was obtained from all subjects.
Microsatellite and SNP Genotyping
The original genome screen marker set comprised 13 mi-
crosatellite markers from the chromosome 20 ABI Linkage
Mapping Panel (v. 2.0). An additional 59 fine-map microsat-
ellite markers demonstrating high heterozygosity (70%) and
distributed uniformly across the regions of maximal linkage
were selected from the Marshfield Clinic database. Microsat-
ellite genotyping was performed as described elsewhere.15
A 1.34-Mb interval of 20q13.1, defined by the markers
rs2425688 and rs2425817 (44237049–45580708; hg16 [Hu-
man Genome Assembly, July 2003]), was targeted for SNP
genotyping. The markers were selected from a publicly avail-
able database of 711 polymorphic markers in the 1.34-Mb
region of interest (1 marker/1.9 kb).28 Assays for the Illumina
Bead Lab System29 were initially designed for 247 SNPs (1
marker/5.4 kb). To test common protein coding variation, we
typed 30 “double-hit” missense SNPs (observed by at least
two independent submitters to dbSNP). In addition, we se-
lected an efficient set of 217 tagging SNPs (tSNPs) by filtering
out most of the perfect and near-perfect proxies, using a pair-
wise method, such that each of the 711 known SNPs of the2r
reference panel were captured by a tSNP with a minimal of2r
0.7 (P. de Bakker, personal communication). Genotyping was
performed using an Illumina Bead Lab System29 at the Broad
Institute of M.I.T. and Harvard. One hundred sixty-two SNPs
were polymorphic and passed strict quality-control filters
(Hardy-Weinberg equilibrium [HWE] , fewer than twoP 1 .01
Mendelian errors, and 195% genotyping efficiency). Seventeen
SNPs were excluded from the analysis for the following rea-
sons: 14 were monomorphic in this sample, 2 were out of
HWE, and 1 failed to genotype in 13% of the subjects. No
SNPs were excluded on the basis of non-Mendelian inheri-
tance. The two SNPs that failed HWE in both the entire and
white samples did not demonstrate any significant results for
the transmission/disequilibrium test (TDT), pedigree disequi-
librium test (PDT), or haplotype runs test (HRT) among the
white pedigrees and showed only suggestive evidence by HRT
in the complete data set.
Statistical Methods
Multipoint NPL analysis.—In all pedigrees reported, each
marker was examined for Mendelian inconsistencies with the
use of PedCheck,30 and sporadic problem genotypes were con-
verted to “missing” status. Allele frequency estimates were
computed using maximum-likelihood methods implemented in
the software RECODE (D. Weeks, personal communication).
Map distances were based on the Marshfield genetic map,31
for the linkage analysis of the microsatellite data. The physical
map based on the May 2004 freeze was used for the association
and haplotype analyses of the SNP markers.
NPL regression analysis, by use of the NPLpairs statistic, was
computed. The NPL regression approach is a conditional lo-
gistic regression analysis in which the family-specific NPL sta-
tistics (e.g., NPLpairs) at one or more loci are the predictor
variables. Consider a sample of m independent pedigrees and
a chromosomal region with one or more markers and a locus
of interest. Let ti be the pedigree-specific contribution to the
NPL statistic at the locus of interest. The likelihood function
for a conditional logistic regression with ti as a predictor is
m
exp {yt b}i iLik(b;y ,t)∝ .i [ ]
ip1 1exp {t b}i
Here, for all i, and is the conditional logistic regressiony p 1 bi
parameter. NPL regression tests whether the observed inheri-
tance at a marker deviates from proportions expected under
independent assortment—that is, whether allele sharing among
affected relatives is greater than expected. It can be shown that
the tests from this likelihood are asymptotically equivalent to
Whittemore and Halpern’s32 class of tests33–36 implemented in
Genehunter.37 Although unaffected individuals can be used to
help estimate the possible inheritance vectors for that pedigree,
an NPL regression analysis is an “affecteds-only” analysis. The
primary advantage of the NPL regression approach is that it
allows us to evaluate simultaneously, either by joint or con-
ditional hypothesis tests, the effects of multiple loci (i.e., het-
erogeneity) and to test for interactions among sets of loci (e.g.,
epistasis). In addition, the NPL regression approach allows for
tests of whether the magnitude of sharing at a locus varies by
environmental or other phenotypic factors (gene-phenotype
interactions). To test for an interaction between two loci, we
included the two loci and their statistical interaction in the
model and computed the 1-df test of the interaction coefficient.
In addition, we tested for interactions between the degree of
sharing (identity by descent [IBD]) at a locus and the American
College of Rheumatology (ACR) criteria. The basic linkage
analysis was confirmed through use of the exponential allele-
sharing model implemented in Genehunter-Plus.38 Both single-
point and multipoint analyses were computed, although only
multipoint results are reported.
OSA.—We computed a series of OSAs, to test whether the
evidence for linkage on chromosome 16q12 influenced the evi-
dence for linkage on chromosome 20p12 or 20q13.39 For this
analysis, a locus was selected within the 16q12 linkage inter-
val, and the family-specific NPLpairs statistics (covariate) were
ranked from largest to smallest. Families were sequentially
added to the linkage analyses by rank of the NPLpairs statistic
at the 16q12 position, and the corresponding LOD scores were
computed across chromosome 20 for that family. This process
was repeated until all families were added to the linkage anal-
ysis. The subset of families that yielded the largest LOD score
at 20p12 or 20q13.1 was taken as the OSA-defined family
subset. The statistical significance of the change in the LOD
score from the complete family set (230 families) to the OSA-
defined family set was evaluated by a permutation test, under
the null hypothesis that the ranking of the NPLpairs statistic on
chromosome 16 is independent of the LOD score on chro-
mosome 20. The resulting empirical P values for the change
in the LOD scores were adjusted for all comparisons made in
the respective regions of 20p12 and 20q13.1 (i.e., regionwide
P value). The OSAs were computed, with subsets at 51 cM,
56 cM, 57 cM, and 62 cM on chromosome 16.
Overlap in pedigrees contributing to linkage at 20p12 and
20q13.1.—It is interesting to consider the overlap in the ped-
igrees contributing to the two linkage signals on chromosome
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Table 1
Summary of Clinical and Demographic Features for SLE Family
Cohorts
SLE Family Trait
Cohorts I
and II Cohort III Total
Pedigree structure:
No. of pedigrees 187 43 230
No. of sib pairs 207 44 251
No. of avuncular pairs 5 7 12
No. of cousin pairs 7 4 11
No. of subjects 399 94 493
Subject demographics:
Female (%) 98.5 89.4 96.8
Ethnicity (%):
White 79.4 75.5 78.7
African American 9.8 8.5 9.5
Other 10.8 16 11.8
ACR criteria in subjects (%):
Malar rash 69.9 50 66.1
Discoid rash 12.3 8.5 11.6
Photosensitivity 82 52.1 76.3
Oral/nasal ulcers 56.9 43.6 54.4
Joint inflammation 79.5 73.4 78.3
Pleurisy or pericarditis 57.9 45.7 55.6
Renal disorder 30.8 38.3 32.3
Neurologic disorder 26.6 14.9 24.3
Hemolytic disorder 50.9 40.4 48.9
Immunologic disorder 56.9 55.3 56.6
Positive ANA 98.5 97.9 98.4
20. In the entire sample, there were 52 families (22.5%) con-
tributing evidence for linkage to 20p12, 51 families (22.1%)
contributing evidence to 20q13.1, 60 families (26%) contrib-
uting to both regions, and 67 families (29.4%) contributing
to neither of these two regions. From the entire sample, we
estimate that 151 of the 492 individuals (31%) had at least
one recombination between the two subsetting loci on chro-
mosome 16 (16 cM apart). The total number of recombina-
tions was estimated to be 181 (37%); this number includes
double recombinations as two recombinations. This number
is slightly higher than expected, but we reexamined the ge-
notypes for error and include data only for those individuals
for whom we are confident in the allele calls. The overlap in
pedigrees, on the basis of OSA, is 25 pedigrees (10.8%) con-
tributing linkage evidence to 20p12, 20 (8.7%) to 20q13.1,
20 (8.7%) to both 20p12 and 20q13.1, and 166 (71.9%) to
neither of these two regions. The 166 pedigrees not contrib-
uting evidence for linkage to either region include the pedigrees
that do not link to chromosome 16. From these data, we con-
clude that the number of recombinations clearly generates par-
tially independent and partially overlapping subsets of pedi-
grees that contribute to the respective linkage signals.
Family-based association analysis.—Each marker was tested
for departures from HWE proportions with the use of a x2
goodness-of-fit test. To test for evidence of association in the
presence of linkage, single-locus and haplotypic TDT and PDT
results were computed.40 The haplotypic PDT uses the expec-
tation-maximization algorithm to estimate the haplotype fre-
quencies and is generally robust to potential population
stratification.
When a variant arises in a population, either through mu-
tation or migration, it will tend to be associated with relatively
few haplotypes. If that variant is either older than or younger
than background haplotypes, it will, on average, tend to be
associated with either shorter (older variant) or longer (youn-
ger variant) haplotypes. The HRT tests whether haplotypes
transmitted to an affected offspring tend to be different in
length than haplotypes not transmitted to affected offspring.41
The form of the HRT used here weights haplotypes by the
inverse of the marker-allele frequencies. The HRT results were
computed using the probands from each pedigree. The statis-
tical significance of the sum of the natural logarithms (SOL)
of the similarity scores and three similarity score thresholds
(1100, 110,000, and 11,000,000) are estimated under a per-
mutation test.
Results
A total of 230 multiplex SLE families were studied—
187 pedigrees that were reported elsewhere18 and 43
newly recruited pedigrees. The clinical and demographic
features of these pedigrees are summarized in table 1.
In brief, the pedigrees were predominately of self-re-
ported white descent, and SLE-affected individuals were
almost exclusively female. All affected individuals met
the 1997 revised ACR criteria for the diagnosis of SLE.
Chromosome 20p12
Multipoint NPL analysis performed using NPL re-
gression for the 13 genome screen microsatellite markers
provided evidence of linkage to 20p12 near D20S186
( , ) (fig. 1). After typing addi-LODp 2.57 Pp .0006
tional fine-mapping microsatellite markers, the maximal
evidence for linkage in this region was modestly reduced
and was shifted 820 kb telomeric of the original max-
imum (D20S894, , ) (fig. 1 andLODp 1.90 Pp .0031
table 2). In addition, the 1-LOD support interval de-
creased from 16 cM to 9.5 cM.
Previous analyses suggested the presence of epistasis
between the loci on chromosome 20 and chromosome
16q12, a region of significant linkage in our family col-
lection and in others (C. Langefeld, unpublished data).
We sought to exploit this potential interaction as a
means to identify homogeneous subsets of families with
enhanced linkage on chromosome 20. To do so, a series
of OSAs39 were computed by conditioning on LOD
scores obtained at 1-cM intervals from 47 cM to 67 cM
across the region of maximal linkage at chromosome
16q12. Conditioning on chromosome 16 (positions 56
cM and 57 cM) yielded significant increases in linkage
at 20p12 (table 3 and fig. 2A). Position 57 cM on chro-
mosome 16 identified 32 pedigrees (14% of total) dem-
onstrating maximal increase in LOD score to 5.06 at
20p12, near marker D20S604, which is located 1.9 Mb
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Table 2
Summary of NPL Results
Region
and Subset
Genome Scan
LOD
Nearest
Marker
Fine-Map
LOD
Nearest
Marker
20p12:
Overall 2.57 D20S186 1.90 D20S894
White 2.84 D20S186 2.12 D20S894
20q13.1:
Overall 1.28 D20S119 1.49 D20S119
White 1.64 D20S119 2.06 D20S119
Figure 1 Microsatellite mapping of chromosome 20. LOD scores were calculated using NPL regression statistics and were plotted as a
function of genetic distance (cM) along the length of chromosome 20. The LOD score data were derived using 13 genome screen microsatellite
markers in 187 SLE sib pair families (solid line), the same 13 markers in 230 families (including the same 187 SLE sib pair families) (coarse
hatched line), and a total of 72 markers, many of which are concentrated in the regions of maximal linkage, in the full 230-family set (fine
hatched line). For clarity, only selected markers are shown at the top of the figure.
centromeric to D20S894, the best marker in the full
family set (fig. 2A). The increase in the LOD score to
5.06 was statistically significant ( ). These P val-Pp .01
ues are adjusted for all possible tests via permutation
methods across the entire chromosome 20. We note that,
if the analysis is restricted to white females affected with
SLE and the subsetting on chromosome 16q12 is at 51
cM, the LOD score around the D20S604/D20S163 re-
gion, on the basis of 80% of the pedigrees, is 3.87
( ). This result shows that the 20p12 linkage isPp .03
not restricted to a small number of pedigrees—72 of the
147 pedigrees (49%) had strictly positive NPLpairs sta-
tistics, and only 52 (35%) had strictly negative NPLpairs
statistics. Thus, these data support the conclusion that
the subset of pedigrees that link to 16q12 also strongly
link to 20p12.
Chromosome 20q13.1
In the 20q13.1 region, the multipoint NPL regression
analysis using the 13 genome screen markers provided
modest evidence for linkage near D20S119 (LODp
, ) for the full 230-pedigree collection (fig.1.28 Pp .01
1 and table 2). Analysis of the white-only pedigrees in-
creased the evidence for linkage to at theLODp 1.64
same locus. The addition of 59 fine-map markers in-
creased maximum LOD scores at the same locus (20q13,
D20S119) to 1.49 ( ) and 2.06 ( ) inPp .009 Pp .002
the entire and white samples, respectively. Similar to
20p12, the linkage at 20q13 appears to be predomi-
nately concentrated in the white pedigrees.
The OSA on 20q13.1 identified three positions on
chromosome 16 for which the change in LOD score on
20q13.1 was significant (positions 42, 43, and 45 cM)
(fig. 2B and table 3). A 33-pedigree subset conditioned
on linkage at position 45 cM on chromosome 16 dem-
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Table 3
Summary of OSA
CHROMOSOMAL REGION LOD SCOREa
NO. OF
PEDIGREES
USED
Chromosome
16 Position
Chromosome
20 Maximized
Position
Nearest
Marker
All
Pedigrees
Subset
Pedigrees
Empirical
P Valueb
% OF TOTAL
PEDIGREES
56 33.9 (20p12) D20S186 1.80 4.39 .0158 45 19
57 35.9 (20p12) D20S604 1.44 5.06 .0101 32 14
42 69.4 (20q13.1) D20S119 1.49 3.14 .0122 36 16
43 69.4 (20q13.1) D20S119 1.49 3.40 .0050 40 17
45 69.4 (20q13.1) D20S119 1.49 3.65 .0035 33 14
a NPL regression-based LOD score at chromosome 20 position.
b Chromosomewide empirical P value for the difference between the entire sample LOD and the subset LOD.
onstrated maximal increase in LOD score to 3.65 near
marker D20S861, ∼1 Mb centromeric to D20S119,
which was the best marker in the full family set.
To more precisely define the linkage effects on
20q13.1, we genotyped 162 SNPs in an ∼1.3-Mb region
of maximal linkage on 20q13.1 bounded by markers
rs2425688 and rs2425817. SNP genotype data was
analyzed in the full sample, the white-only sample, and
the OSA-defined family sets, by use of the TDT, PDT,
and HRT.41 In the full 230-family set, the HRT demon-
strated a broad range of significance ( ) fromP  .05
marker rs6031869 (44.24 Mb) to marker rs2251212
(44.73 Mb) (482 kb total distance), an interval that
included the following genes: TOMM34, STK4,
KCNS1, WFDC2, WFDC5, WFDC12, PI3, SEMG1,
SEMG2, SLPI, MATN4, RBPSUHL, SDC4, C20orf10,
C20orf35, and PIGT (fig. 3). Maximal significance by
the HRT was centered around two regions—the centro-
meric WFDC gene cluster and the MATN4 gene (44.44
Mb and 44.62 Mb, respectively) (fig. 3). Within the first
region (44.42 Mb) in the full 230-family set, rs6032006,
located within the WFDC12 gene, provided the stron-
gest evidence of association with the HRT (SOL Pp
and 1100 ) and the TDT ( ),.0008 Pp .0011 Pp .0446
but not with the PDT ( ) (table 4). Neighbor-Pp .2156
ing SNPs were significant with the HRT, but not with
the TDT or the PDT, at the level. RepeatingPp .05
these analyses in the white pedigrees yielded comparable
evidence of association at rs6032006. However, neigh-
boring SNPs rs2664581 within the PI3 gene (HRT SOL
, HRT 1100 , and TDTPp .0013 Pp .005 Pp
), rs2233896 within the SEMG2 gene (HRT SOL.0465
, HRT 1100 , and TDTPp .0014 Pp .0042 Pp
), and rs6032064 within the SEMG2 gene (HRT.0465
SOL , HRT 1100 , and TDTPp .0030 Pp .0058
) also provided supporting evidence of asso-Pp .0329
ciation (table 4).
The next peak of HRT significance was located within
the MATN4 gene region (44.62 Mb) (fig. 3). SNPs
rs2072788 and rs2072787 provided the strongest evi-
dence of association in the full pedigree set, including
the only significant evidence by the PDT analyses (HRT
SOL , HRT 1100 , TDTPp .0058 P ! .0001 Pp
, and PDT ) (HRT SOL ,.0429 Pp .0448 Pp .0081
HRT 1100 , TDT , and PDTPp .0001 Pp .0705
) (table 4). In the entire sample, the evidencePp .0448
of association by the TDT and PDT quickly decayed at
neighboring markers. However, within the white pedi-
grees, the evidence of association for the TDT, but not
for the PDT, extended to neighboring SNPs rs2741500
within the RBPSUHL gene (HRT SOL , HRTPp .0086
1100 , and TDT ) and rs2743345Pp .0003 Pp .0481
(HRT SOL , HRT 1100 , and TDTPp .0272 Pp .0006
). Repeating these analyses in the OSA-de-Pp .0165
fined subset of pedigrees did not strengthen the evidence
of association within these two regions beyond that re-
ported above.
The HRT also identified a smaller region of signifi-
cance, from marker rs6065921 to marker rs2425754
(fig. 3). The HRT achieved maximal statistical signifi-
cance at rs1535045 (HRT SOL and HRTPp .0117
1100 ) within the TNFRSF5 (CD40) gene.Pp .0022
Two SNPs flanking the CD40 gene exhibited statistical
significance for both the TDT and HRT: rs6065926
(HRT SOL , HRT 1100 , TDTPp .0251 Pp .0040
, and PDT ) and rs2064405 (HRTPp .0424 Pp .3579
SOL , HRT 1100 , TDTPp .0409 Pp .0461 Pp
, and PDT ). These results appear to be.0101 Pp .4074
concentrated in the nonwhite pedigrees, since the sig-
nificance of this effect was reduced in the white-only
analysis.
In the 40 pedigrees identified by OSA at position 43
on chromosome 16, the HRT analysis exhibited signif-
icance over a broader region, from marker rs2425688
to marker rs6094192 (746 kb total distance). However,
the region of peak significance shifted 4.3 kb down-
stream from the MATN4 SNP rs2072788 to a region
centering over SDC4 (fig. 3). The marker displaying the
strongest evidence of association within the OSA sub-
set of pedigrees was rs2072786 (HRT SOL ,P ! .0001
752
Figure 2 OSA for chromosome 20p12 and 20q13.1. OSA was performed as described in the “Material and Methods” section. A, OSA
results for chromosome 20p12 conditioned on linkage to positions 56 cM and 57 cM on chromosome 16 (hatched lines). LOD score results
from the full set of 230 sib pair families and 72 microsatellite markers are shown for comparison (solid line). B, OSA results for the 20q13.1
region conditioned on linkage at positions 42 cM, 43 cM, 45 cM, and 47 cM on chromosome 16 (hatched lines). The positions of selected
microsatellite markers are shown in the upper portion of each panel.
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Figure 3 Summary of family-based and haplotype association analysis for selected SNPs from the region of 20q13.1. Seventy SNPs
demonstrating the most-significant evidence with family-based PDT, TDT, and haplotypic association HRT are shown. The statistical significance
for the HRT is shown as the SOL of the similarity scores and as three similarity score thresholds (1100, 110,000, and 11,000,000) estimated
under a permutation test. The evidence for association is represented on a gray scale, as shown in the key to the right. The analyses were
performed on the full 230-pedigree family set, the 181-pedigree white family set, and the OSA-defined set of 40 pedigrees conditioned on linkage
to position 43 on chromosome 16. The SNPs italicized in bold demonstrate the strongest evidence of association.
Table 4
Summary of Association Data for Selected SNPs in the 20q13.1 Region
SNP GENE POSITION
PDT
P
VALUE
TDT
P
VALUE
HRTa
SOL 1102 1104 1106
Full family set ( ):Np 230
rs6032006 WFDC12 44440482 .2156 .0446 .0008 .0011 .0378 .4593
rs2664581 PI3 44489951 .4360 .0807 .0013 .0016 .0470 .4960
rs2233896 SEMG2 44535829 .5807 .0654 .0013 .0014 .0443 .4969
rs6032064 44540256 .5976 .0654 .0028 .0020 .0568 .5115
rs2072788 MATN4 44618450 .0448 .0429 .0058 .0001 .0586 .6031
rs2072787 MATN4 44619389 .0448 .0705 .0081 .0001 .0594 .6726
rs2741500 RBPSUHL 44630387 .8315 .1255 .0107 .0001 .0657 .5977
rs2743345 44632579 .5526 .0858 .0264 .0002 .1114 .5899
rs2076025 SDC4 44641620 .5840 .0269 .0773 .0103 .1848 .5542
rs2267868 SDC4 44655269 .8284 .0151 .1036 .0804 .0709 .3683
rs2743389 SDC4 44659166 .2742 .0270 .0709 .0250 .0310 .0892
rs2072786 SDC4 44661710 .6450 .0984 .0422 .0116 .0162 .0743
rs6065926 45421276 .3579 .0424 .0251 .0040 .0119 .0761
rs1535045 TNFRSF5 45433521 .8542 .5736 .0117 .0022 .0075 .0593
rs2064405 45462927 .4074 .0101 .0409 .0461 .0673 .1008
Whites ( ):Np 181
rs6032006 WFDC12 44440482 .2167 .0302 .0008 .0036 .0539 .4502
rs2664581 PI3 44489951 .2946 .0465 .0013 .0050 .0614 .4694
rs2233896 SEMG2 44535829 .4442 .0465 .0014 .0042 .0591 .4707
rs6032064 44540256 .4608 .0329 .0030 .0058 .0642 .4757
rs2072788 MATN4 44618450 .0676 .0482 .0097 .0005 .0801 .5438
rs2072787 MATN4 44619389 .0676 .0830 .0172 .0016 .1121 .6176
rs2741500 RBPSUHL 44630387 .5267 .0481 .0086 .0003 .1006 .5334
rs2743345 44632579 .9517 .0165 .0272 .0006 .1740 .5339
rs2076025 SDC4 44641620 .3582 .0099 .0860 .0123 .2393 .4480
rs2267868 SDC4 44655269 .7284 .0098 .0841 .0459 .1053 .1839
rs2743389 SDC4 44659166 .1792 .0303 .0430 .0079 .0381 .0514
rs2072786 SDC4 44661710 .6778 .1807 .0282 .0060 .0240 .0446
rs6065926 45421276 .2810 .0361 .0270 .0134 .0191 .0655
rs1535045 TNFRSF5 45433521 .2130 .2921 .0107 .0124 .0176 .0527
rs2064405 45462927 .4382 .0145 .1008 .2407 .1140 .1294
OSA subset position 43 ( ):Np 40
rs6032006 WFDC12 44440482 .6971 .7452 .0011 .1213 .0281 .0095
rs2664581 PI3 44489951 .6971 .5475 .0024 .2585 .0309 .0070
rs2233896 SEMG2 44535829 .6971 .7595 .0011 .1365 .0214 .0066
rs6032064 44540256 .6971 .7595 .0027 .2860 .0207 .0072
rs2072788 MATN4 44618450 .0548 .1482 .0012 .0151 .0195 .0095
rs2072787 MATN4 44619389 .0548 .1505 .0012 .0322 .0295 .0106
rs2741500 RBPSUHL 44630387 .8216 .5508 .0022 .0382 .0322 .0115
rs2743345 44632579 .8815 .3199 .0039 .0597 .0352 .0076
rs2076025 SDC4 44641620 .1218 .1545 !.0001 .0328 .0011 !.0001
rs2267868 SDC4 44655269 .8694 .5312 !.0001 .0166 .0002 !.0001
rs2743389 SDC4 44659166 .2467 .0857 !.0001 .0028 !.0001 !.0001
rs2072786 SDC4 44661710 .1907 .0026 !.0001 .0006 .0001 !.0001
rs6065926 45421276 .4281 .4383 .4532 .5822 .3048 .5083
rs1535045 TNFRSF5 45433521 .2294 .7675 .5280 .5449 .3707 .6647
rs2064405 45462927 .6547 .0916 .5800 .3959 .4102 .6611
a HRT 1102, 1104, and 1106 represent three similarity score thresholds (1100, 110,000, and 11,000,000, respectively)
estimated under a permutation test that approximates short, intermediate, and long haplotypes, respectively. SOL is the sum
of the natural logarithms of the similarity scores.
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HRT 1100 , TDT , and PDTPp .0006 Pp .0026
). Three neighboring SNPs within the SDC4Pp .1907
gene (rs2076025, rs2267868, and rs2743389) were also
significant by TDT in the full family and white-only
analyses, although the HRT evidence for these SNPs was
weaker. No statistically significant association was ob-
served between any these SNPs and the presence of var-
ious ACR disease criteria.
Discussion
These data provide additional evidence that SLE-pre-
disposing genes reside within the greater chromosome
20p12 and 20q13 linkage regions. The evidence for link-
age and association was observed in an expanded set of
sib pair and multiplex families, with the use of 72 chro-
mosomewide microsatellite markers and 162 SNPs tar-
geted to a 1.34-Mb region of maximal linkage on
20q13.1. Our results compare favorably with those re-
ported in independent, ethnically diverse SLE family col-
lections that used a variety of experimental designs.14,
16,22 First, Shai et al.16 reported evidence for linkage with
the use of nonparametric methods in Mexican Ameri-
can ( ) and white ( ) families at 20p12Np 43 Np 37
(D20S115, ), ∼3.86 Mb telomeric to D20S186,Pp .012
the best marker at 20p12 in the Minnesota pedigrees.
Second, Tsao et al.22 identified linkage to the 20p12 re-
gion (D20S162, ; D20S604, ) in aPp .005 Pp .03
mixed-ethnicity cohort of 145 SLE-affected sib pairs.
Markers D20S162 and D20S604 are located 1.48 Mb
telomeric and 1.06 Mb centromeric of D20S186, re-
spectively. Similar to the Minnesota pedigrees, linkage
to 20p12 in the Tsao et al.22 study was contributed pri-
marily by white ( ), as opposed to nonwhiteNp 77
( ), affected sib pairs. Third, Moser et al.14 re-Np 68
ported evidence for linkage to chromosome 20q13 in a
collection of 94 multiplex pedigrees at marker D20S481
( ), 120 kb telomeric from the best markerLODp 2.49
reported in the Minnesota pedigrees (D20S119). Again,
the white multiplex SLE families contributed predomi-
nantly to this score.
In addition to SLE, linkage to 20q has been reported
in families with Grave’s disease, a condition character-
ized by autoimmune hyperthyroidism.42,43 A major ge-
netic effect in Grave’s disease has been mapped to a
region ∼13 cM centromeric to D20S119, near marker
D20S195. Recent genome scan results in families ascer-
tained for multiple autoimmune diseases through the
Multiple Autoimmune Diseases Genetic Consortium
also provide evidence for linkage to chromosome 20 (P.
Gregersen, personal communication). The strongest
linkage evidence in this study was obtained in a subset
of families classified as having SLE or in unaffected in-
dividuals with high levels of autoantibodies to various
antigens, including SSA, SSB, SM, RNP, SCL70, JO1,
RIBO, or chromatin. An NPL LOD score of 3.5 was
obtained at ∼95 cM, a region 25 cM telomeric to the
20q13.1 linkage effect described here (P. Gregersen, per-
sonal communication). These observations suggest the
presence of multiple autoimmune-predisposing genes on
chromosome 20 that individually may have dominant
roles in specific autoimmune diseases. At present, it is
not possible to determine if these effects act in concert
to influence autoimmune susceptibility.
The sum of the genetic evidence to date supports the
hypothesis that SLE is a complex genetic disease. Thus,
we expect to observe genetic heterogeneity and gene-
gene and gene-environment interactions, all of which
limit the power of linkage and association methods.
Methods that attempt to account for genetic and envi-
ronmental heterogeneity are attractive means to identify
homogeneous subsets of families enriched for specific
linkage and/or association effects. In this study, we em-
ployed two relatively recent methods (NPL regression
and OSA) to explore the potential epistatic relationships
among loci within the linkage peak on chromosome
16q12 and the loci on chromosome 20. OSA has the
advantage of not requiring a priori specification of co-
variate trait cutoffs, which, depending on the covariate,
may not be intuitively obvious. NPL regression and/or
OSA has been successfully used to refine disease-gene
location estimates in a variety of complex diseases, in-
cluding macular degeneration,44 autism,45 multiple scle-
rosis,46 and diabetic nephropathy.47 The OSA analysis
identified SLE family subsets that share significant link-
age to both 16q12 and 20p12 or 20q13.1, consistent
with the epistasis hypothesis. Further studies are needed
to determine if specific gene families or pathways rep-
resented in these chromosomal regions work coordi-
nately in SLE pathophysiology.
The data presented here provide the first evidence for
family-based association between genetic markers on
chromosome 20 and SLE. A unique aspect of our anal-
ysis was the use of a novel haplotype-based analysis
method, the HRT.41 This test evaluates shared consec-
utive identical-by-state allele matches between haplo-
types around a reference marker. Weights are then as-
signed as an inverse function of allele frequencies at
markers within the shared haplotype. HRT is similar in
its philosophy to other haplotype-sharing statistics (e.g.,
maximum identity length statistic48 and haplotype-shar-
ing statistic49) but does not require allele or haplotype
removal because of small sample sizes or the use of ex-
cess degrees of freedom.41 Given the differences in the
hypothesis being tested, it is not surprising that the HRT
and PDT/TDT can differ in statistical significance for a
particular SNP. Specifically, the HRT emphasizes differ-
ences in length of haplotypes, whereas the PDT/TDT
emphasizes pure association with a specific haplotype.41
Importantly, the SNPs with the strongest evidence for
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association within the 20q13.1 region reside within po-
tentially interesting candidate genes. In the full family
set, the strongest evidence ( for PDT, TDT,P ! .05
and HRT) points to MATN4 as a putative candidate.
MATN4 encodes the protein matrilin 4. Matrilins are a
group of noncollagenous extracellular matrix proteins
that share von Willebrand factor A domains impor-
tant for protein-protein interactions.50 Although widely
expressed in human tissues, the molecular function of
matrilin 4 is unknown; thus, the mechanism by which
matrilin 4 might lead to autoimmunity is equally un-
clear. Antibodies to a closely related family member,
matrilin 1 (MATN1 [MIM 115437]), are hypothesized
to play a role in the autoimmune disease relapsing
polychondritis.51
In the OSA family set, the association evidence sug-
gests a possible role for SDC4. SDC4 encodes the protein
syndecan 4, which belongs to a family of transmembrane
heparan sulfate proteoglycans that appear to act as re-
ceptors or coreceptors involved in intracellular signal-
ing.52 Syndecan 4 has a number of activities, including
modulation of fibroblast growth factor signaling,53 reg-
ulation of cell migration via cross talk with integrins,54
and control of adhesion via cytoskeletal modifications.55
Syndecan 4 is expressed from an early pro–B cell step
through immature and mature B cell stages.56 It is al-
most, but not entirely, restricted to B lymphocyte lineage
cells in bone marrow and is absent from B cells that have
undergone Ig isotype switching.56 Syndecan 4 ligation
on activated B lymphocytes leads to dramatic morpho-
logical changes and extrusion of prominent filopodia,
which may facilitate signaling and migration.56 In coim-
munoprecipitation experiments, syndecan 4 has also
been shown to be a potential binding partner for the
chemokine receptor 4 (CXCR4).57 This syndecan 4/
CXCR4 complex is likely a functional unit involved in
stromal cell–derived factor-1 (SDF-1) signaling.57 Al-
though it is premature to implicate any of the genes
identified here as a lupus susceptibility gene without con-
firmation from independent SLE cohorts, these data sug-
gest that a detailed investigation of these regions might
be fruitful.
In summary, the data presented here support the hy-
pothesis that SLE susceptibility genes reside on chro-
mosome 20. In addition, we provide evidence suggesting
an epistatic interaction between loci on chromosome 16
and chromosome 20 in an OSA-defined subset of our
SLE families. This type of information may be useful in
selecting families enriched for particular genetic effects
as part of future fine-mapping and resequencing efforts.
In addition, large-scale genomewide association studies
employing staged case/control designs and high-density
SNP arrays—currently under way under the auspices of
the SLE Genetics (SLEGEN) consortium—will likely
lead to enhanced characterization of the causal variants
that influence SLE susceptibility on chromosome 20.
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